SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-029240
Filing Date
2023-08-17
Accepted
2023-08-17 08:30:22
Documents
14
Period of Report
2023-08-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39751
2 ex99-1.htm EX-99.1 56921
3 ex99-1_001.jpg GRAPHIC 5776
  Complete submission text file 0001493152-23-029240.txt   288995

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20230817.xsd EX-101.SCH 3015
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20230817_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20230817_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3413
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 231179879
SIC: 2834 Pharmaceutical Preparations